Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Geller

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Contemporary Clinical Trials|August 14, 2021
Implementing family-based behavioral treatment in the pediatric primary care setting: Design of the PLAN studyLeonard H Epstein, Kenneth B Schechtman, Colleen Kilanowski, et al.
British Journal of Haematology|March 1, 2011
A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteersSteven J Lemery, Matthew M Hsieh, Aleah Smith, et al.
JACC. Cardiovascular Interventions|March 21, 2021
Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y<sub>12</sub> Inhibitor Therapy: A Meta-AnalysisNaveen L Pereira, Charanjit Rihal, Ryan Lennon, et al.
The Journal of Clinical Investigation|February 23, 2008
Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cellsYoshiyuki Takahashi, Nanae Harashima, Sachiko Kajigaya, et al.
American Heart Journal|July 2, 2005
Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) studyAnne B Curtis, Bernard J Gersh, Scott D Corley, et al.
American Heart Journal|November 1, 2020
Rationale and design of the TAILOR-PCI digital study: Transitioning a randomized controlled trial to a digital registryNaveen L Pereira, Robert Avram, Derek Y So, et al.
Journal of Clinical and Translational Science|December 2, 2024
Erratum: The statistical design and analysis of pandemic platform trials: Implications for the future - CORRIGENDUMChristopher J Lindsell, Matthew Shotwell, Kevin J Anstrom, et al.
Journal of Clinical and Translational Science|November 14, 2024
The statistical design and analysis of pandemic platform trials: Implications for the futureChristopher J Lindsell, Matthew Shotwell, Kevin J Anstrom, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2013
Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSFAndreas Lundqvist, Aleah L Smith, Yoshiyuki Takahashi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 23, 2019
Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 TrialSergio Giralt, Luciano J Costa, David Maloney, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Contemporary Clinical Trials|August 14, 2021
Implementing family-based behavioral treatment in the pediatric primary care setting: Design of the PLAN studyLeonard H Epstein, Kenneth B Schechtman, Colleen Kilanowski, et al.
British Journal of Haematology|March 1, 2011
A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteersSteven J Lemery, Matthew M Hsieh, Aleah Smith, et al.
JACC. Cardiovascular Interventions|March 21, 2021
Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y<sub>12</sub> Inhibitor Therapy: A Meta-AnalysisNaveen L Pereira, Charanjit Rihal, Ryan Lennon, et al.
The Journal of Clinical Investigation|February 23, 2008
Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cellsYoshiyuki Takahashi, Nanae Harashima, Sachiko Kajigaya, et al.
American Heart Journal|July 2, 2005
Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) studyAnne B Curtis, Bernard J Gersh, Scott D Corley, et al.
American Heart Journal|November 1, 2020
Rationale and design of the TAILOR-PCI digital study: Transitioning a randomized controlled trial to a digital registryNaveen L Pereira, Robert Avram, Derek Y So, et al.
Journal of Clinical and Translational Science|December 2, 2024
Erratum: The statistical design and analysis of pandemic platform trials: Implications for the future - CORRIGENDUMChristopher J Lindsell, Matthew Shotwell, Kevin J Anstrom, et al.
Journal of Clinical and Translational Science|November 14, 2024
The statistical design and analysis of pandemic platform trials: Implications for the futureChristopher J Lindsell, Matthew Shotwell, Kevin J Anstrom, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2013
Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSFAndreas Lundqvist, Aleah L Smith, Yoshiyuki Takahashi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 23, 2019
Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 TrialSergio Giralt, Luciano J Costa, David Maloney, et al.
Pageof 6